 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0031492	nucleosomal DNA binding	1	9.457441e-4	1.000000e+0	1.000000e+0	1.057369e+3	9.457441e-4	1	9.457441e-4	1.000000e+0	1	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	HMGN2
GO Molecular Function	GO:0031491	nucleosome binding	2	1.646814e-3	1.000000e+0	1.000000e+0	6.072332e+2	1.646814e-3	1	1.646814e-3	1.000000e+0	2	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	HMGN2
GO Molecular Function	GO:0016765	transferase activity, transferring alkyl or aryl (other than methyl) groups	3	2.834471e-3	1.000000e+0	1.000000e+0	3.527995e+2	2.834471e-3	1	2.834471e-3	1.000000e+0	4	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	DHDDS
GO Molecular Function	GO:0031490	chromatin DNA binding	4	4.680736e-3	1.000000e+0	1.000000e+0	2.136416e+2	4.680736e-3	1	4.680736e-3	1.000000e+0	3	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	HMGN2
GO Molecular Function	GO:0043566	structure-specific DNA binding	5	2.331952e-2	1.000000e+0	1.000000e+0	4.288253e+1	2.331952e-2	1	2.331952e-2	1.000000e+0	5	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	HMGN2
GO Molecular Function	GO:0003682	chromatin binding	6	4.358760e-2	1.000000e+0	1.000000e+0	2.294231e+1	4.358760e-2	1	4.358760e-2	1.000000e+0	6	3.951200e-2	1.000000e+0	1.000000e+0	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	HMGN2
GO Molecular Function	GO:0032403	protein complex binding	7	5.694276e-2	1.000000e+0	1.000000e+0	1.756149e+1	5.694276e-2	1	5.694276e-2	1.000000e+0	7	6.272959e-2	1.000000e+0	1.000000e+0	1.568783e+1	6.374369e-2	1	575	5.000000e-1	1.739130e-3	unnamed	HMGN2
GO Molecular Function	GO:0016740	transferase activity	8	1.774445e-1	1.000000e+0	1.000000e+0	5.635566e+0	1.774445e-1	1	1.774445e-1	1.000000e+0	8	1.943792e-1	1.000000e+0	1.000000e+0	4.881223e+0	2.048667e-1	1	1848	5.000000e-1	5.411255e-4	unnamed	DHDDS
GO Molecular Function	GO:0003677	DNA binding	9	2.170876e-1	1.000000e+0	1.000000e+0	4.606435e+0	2.170876e-1	1	2.170876e-1	1.000000e+0	10	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	HMGN2
GO Molecular Function	GO:0003676	nucleic acid binding	10	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	11	3.411408e-1	1.000000e+0	1.000000e+0	2.655431e+0	3.765867e-1	1	3397	5.000000e-1	2.943774e-4	unnamed	HMGN2
GO Molecular Function	GO:1901363	heterocyclic compound binding	11	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	13	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	HMGN2
GO Molecular Function	GO:0097159	organic cyclic compound binding	12	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	14	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	HMGN2
GO Molecular Function	GO:0003824	catalytic activity	13	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	15	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	DHDDS
GO Molecular Function	GO:0005515	protein binding	14	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	9	1.964729e-1	1.000000e+0	1.000000e+0	2.255971e+0	8.865362e-1	2	7997	1.000000e+0	2.500938e-4	unnamed	DHDDS,HMGN2
GO Molecular Function	GO:0005488	binding	15	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	12	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	DHDDS,HMGN2
GO Biological Process	GO:0006486	protein glycosylation	1	2.791430e-2	1.000000e+0	1.000000e+0	3.582393e+1	2.791430e-2	1	2.791430e-2	1.000000e+0	1	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	DHDDS
GO Biological Process	GO:0070085	glycosylation	2	2.852370e-2	1.000000e+0	1.000000e+0	3.505857e+1	2.852370e-2	1	2.852370e-2	1.000000e+0	2	2.861633e-2	1.000000e+0	1.000000e+0	3.469423e+1	2.882324e-2	1	260	5.000000e-1	3.846154e-3	unnamed	DHDDS
GO Biological Process	GO:0009101	glycoprotein biosynthetic process	3	3.592748e-2	1.000000e+0	1.000000e+0	2.783385e+1	3.592748e-2	1	3.592748e-2	1.000000e+0	3	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	DHDDS
GO Biological Process	GO:0009100	glycoprotein metabolic process	4	4.447614e-2	1.000000e+0	1.000000e+0	2.248397e+1	4.447614e-2	1	4.447614e-2	1.000000e+0	4	3.831648e-2	1.000000e+0	1.000000e+0	2.584670e+1	3.868965e-2	1	349	5.000000e-1	2.865330e-3	unnamed	DHDDS
GO Biological Process	GO:0044723	single-organism carbohydrate metabolic process	5	4.905021e-2	1.000000e+0	1.000000e+0	2.038727e+1	4.905021e-2	1	4.905021e-2	1.000000e+0	5	5.638653e-2	1.000000e+0	1.000000e+0	1.748159e+1	5.720304e-2	1	516	5.000000e-1	1.937984e-3	unnamed	DHDDS
GO Biological Process	GO:0006325	chromatin organization	6	5.364312e-2	1.000000e+0	1.000000e+0	1.864172e+1	5.364312e-2	1	5.364312e-2	1.000000e+0	7	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	HMGN2
GO Biological Process	GO:1901137	carbohydrate derivative biosynthetic process	7	6.024060e-2	1.000000e+0	1.000000e+0	1.660010e+1	6.024060e-2	1	6.024060e-2	1.000000e+0	6	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	DHDDS
GO Biological Process	GO:0051276	chromosome organization	8	6.817619e-2	1.000000e+0	1.000000e+0	1.466788e+1	6.817619e-2	1	6.817619e-2	1.000000e+0	9	8.194912e-2	1.000000e+0	1.000000e+0	1.194768e+1	8.369824e-2	1	755	5.000000e-1	1.324503e-3	unnamed	HMGN2
GO Biological Process	GO:0005975	carbohydrate metabolic process	9	7.097916e-2	1.000000e+0	1.000000e+0	1.408864e+1	7.097916e-2	1	7.097916e-2	1.000000e+0	8	8.120541e-2	1.000000e+0	1.000000e+0	1.205949e+1	8.292223e-2	1	748	5.000000e-1	1.336898e-3	unnamed	DHDDS
GO Biological Process	GO:1901135	carbohydrate derivative metabolic process	10	1.134958e-1	1.000000e+0	1.000000e+0	8.810897e+0	1.134958e-1	1	1.134958e-1	1.000000e+0	10	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	DHDDS
GO Biological Process	GO:0006996	organelle organization	11	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	12	2.321362e-1	1.000000e+0	1.000000e+0	4.041443e+0	2.474364e-1	1	2232	5.000000e-1	4.480287e-4	unnamed	HMGN2
GO Biological Process	GO:0006464	cellular protein modification process	12	2.092214e-1	1.000000e+0	1.000000e+0	4.779626e+0	2.092214e-1	1	2.092214e-1	1.000000e+0	11	2.280507e-1	1.000000e+0	1.000000e+0	4.118950e+0	2.427803e-1	1	2190	5.000000e-1	4.566210e-4	unnamed	DHDDS
GO Biological Process	GO:0043412	macromolecule modification	13	2.160048e-1	1.000000e+0	1.000000e+0	4.629527e+0	2.160048e-1	1	2.160048e-1	1.000000e+0	13	2.399849e-1	1.000000e+0	1.000000e+0	3.899914e+0	2.564159e-1	1	2313	5.000000e-1	4.323390e-4	unnamed	DHDDS
GO Biological Process	GO:0044267	cellular protein metabolic process	14	2.533433e-1	1.000000e+0	1.000000e+0	3.947214e+0	2.533433e-1	1	2.533433e-1	1.000000e+0	14	2.989111e-1	1.000000e+0	1.000000e+0	3.073424e+0	3.253700e-1	1	2935	5.000000e-1	3.407155e-4	unnamed	DHDDS
GO Biological Process	GO:0034645	cellular macromolecule biosynthetic process	15	2.892943e-1	1.000000e+0	1.000000e+0	3.456687e+0	2.892943e-1	1	2.892943e-1	1.000000e+0	17	3.331981e-1	1.000000e+0	1.000000e+0	2.726050e+0	3.668311e-1	1	3309	5.000000e-1	3.022061e-4	unnamed	DHDDS
GO Biological Process	GO:0009059	macromolecule biosynthetic process	16	2.955002e-1	1.000000e+0	1.000000e+0	3.384092e+0	2.955002e-1	1	2.955002e-1	1.000000e+0	19	3.377168e-1	1.000000e+0	1.000000e+0	2.685472e+0	3.723740e-1	1	3359	5.000000e-1	2.977077e-4	unnamed	DHDDS
GO Biological Process	GO:0019538	protein metabolic process	17	2.975455e-1	1.000000e+0	1.000000e+0	3.360830e+0	2.975455e-1	1	2.975455e-1	1.000000e+0	20	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	DHDDS
GO Biological Process	GO:0006355	regulation of transcription, DNA-dependent	18	3.043461e-1	1.000000e+0	1.000000e+0	3.285733e+0	3.043461e-1	1	3.043461e-1	1.000000e+0	15	3.260273e-1	1.000000e+0	1.000000e+0	2.792724e+0	3.580733e-1	1	3230	5.000000e-1	3.095975e-4	unnamed	HMGN2
GO Biological Process	GO:2001141	regulation of RNA biosynthetic process	19	3.046463e-1	1.000000e+0	1.000000e+0	3.282495e+0	3.046463e-1	1	3.046463e-1	1.000000e+0	16	3.275736e-1	1.000000e+0	1.000000e+0	2.778103e+0	3.599579e-1	1	3247	5.000000e-1	3.079766e-4	unnamed	HMGN2
GO Biological Process	GO:0051252	regulation of RNA metabolic process	20	3.113245e-1	1.000000e+0	1.000000e+0	3.212082e+0	3.113245e-1	1	3.113245e-1	1.000000e+0	18	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	HMGN2
GO Biological Process	GO:2000112	regulation of cellular macromolecule biosynthetic process	21	3.236874e-1	1.000000e+0	1.000000e+0	3.089400e+0	3.236874e-1	1	3.236874e-1	1.000000e+0	20	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	HMGN2
GO Biological Process	GO:0010556	regulation of macromolecule biosynthetic process	22	3.285042e-1	1.000000e+0	1.000000e+0	3.044101e+0	3.285042e-1	1	3.285042e-1	1.000000e+0	22	3.578608e-1	1.000000e+0	1.000000e+0	2.516881e+0	3.973172e-1	1	3584	5.000000e-1	2.790179e-4	unnamed	HMGN2
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	23	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	23	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	HMGN2
GO Biological Process	GO:0010468	regulation of gene expression	24	3.434880e-1	1.000000e+0	1.000000e+0	2.911310e+0	3.434880e-1	1	3.434880e-1	1.000000e+0	24	3.723475e-1	1.000000e+0	1.000000e+0	2.406750e+0	4.154980e-1	1	3748	5.000000e-1	2.668090e-4	unnamed	HMGN2
GO Biological Process	GO:0009889	regulation of biosynthetic process	25	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	25	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	HMGN2
GO Biological Process	GO:0044249	cellular biosynthetic process	26	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	29	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	DHDDS
GO Biological Process	GO:1901576	organic substance biosynthetic process	27	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	31	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	DHDDS
GO Biological Process	GO:0009058	biosynthetic process	28	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	32	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	DHDDS
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	29	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	26	3.879706e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	3927	5.000000e-1	2.546473e-4	unnamed	HMGN2
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	30	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	27	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	HMGN2
GO Biological Process	GO:0016043	cellular component organization	31	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	28	3.965267e-1	1.000000e+0	1.000000e+0	2.240561e+0	4.463167e-1	1	4026	5.000000e-1	2.483855e-4	unnamed	HMGN2
GO Biological Process	GO:0071840	cellular component organization or biogenesis	32	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	30	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	HMGN2
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	33	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	33	4.477526e-1	1.000000e+0	1.000000e+0	1.946590e+0	5.137188e-1	1	4634	5.000000e-1	2.157963e-4	unnamed	HMGN2
GO Biological Process	GO:0080090	regulation of primary metabolic process	34	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	34	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	HMGN2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	35	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	35	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	HMGN2
GO Biological Process	GO:0019222	regulation of metabolic process	36	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	36	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	HMGN2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	37	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	38	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	DHDDS
GO Biological Process	GO:0043170	macromolecule metabolic process	38	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	39	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	DHDDS
GO Biological Process	GO:0044237	cellular metabolic process	39	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	40	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	DHDDS
GO Biological Process	GO:0044238	primary metabolic process	40	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	41	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	DHDDS
GO Biological Process	GO:0071704	organic substance metabolic process	41	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	42	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	DHDDS
GO Biological Process	GO:0008152	metabolic process	42	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	44	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	DHDDS
GO Biological Process	GO:0050794	regulation of cellular process	43	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	43	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	HMGN2
GO Biological Process	GO:0050789	regulation of biological process	44	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	45	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	HMGN2
GO Biological Process	GO:0065007	biological regulation	45	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	46	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	HMGN2
GO Biological Process	GO:0044763	single-organism cellular process	46	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	47	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	HMGN2
GO Biological Process	GO:0044699	single-organism process	47	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	48	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	HMGN2
GO Biological Process	GO:0009987	cellular process	48	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	37	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0000785	chromatin	1	2.825430e-2	1.000000e+0	1.000000e+0	3.539284e+1	2.825430e-2	1	2.825430e-2	1.000000e+0	1	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	HMGN2
GO Cellular Component	GO:0044427	chromosomal part	2	4.834754e-2	1.000000e+0	1.000000e+0	2.068358e+1	4.834754e-2	1	4.834754e-2	1.000000e+0	2	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	HMGN2
GO Cellular Component	GO:0005694	chromosome	3	5.644203e-2	1.000000e+0	1.000000e+0	1.771729e+1	5.644203e-2	1	5.644203e-2	1.000000e+0	3	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	HMGN2
GO Cellular Component	GO:0005789	endoplasmic reticulum membrane	4	6.490642e-2	1.000000e+0	1.000000e+0	1.540680e+1	6.490642e-2	1	6.490642e-2	1.000000e+0	4	8.534508e-2	1.000000e+0	1.000000e+0	1.146188e+1	8.724572e-2	1	787	5.000000e-1	1.270648e-3	unnamed	DHDDS
GO Cellular Component	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	5	6.714499e-2	1.000000e+0	1.000000e+0	1.489314e+1	6.714499e-2	1	6.714499e-2	1.000000e+0	5	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	DHDDS
GO Cellular Component	GO:0044432	endoplasmic reticulum part	6	7.857548e-2	1.000000e+0	1.000000e+0	1.272662e+1	7.857548e-2	1	7.857548e-2	1.000000e+0	6	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	DHDDS
GO Cellular Component	GO:0005783	endoplasmic reticulum	7	1.167593e-1	1.000000e+0	1.000000e+0	8.564628e+0	1.167593e-1	1	1.167593e-1	1.000000e+0	9	1.436532e-1	1.000000e+0	1.000000e+0	6.701709e+0	1.492157e-1	1	1346	5.000000e-1	7.429421e-4	unnamed	DHDDS
GO Cellular Component	GO:0012505	endomembrane system	8	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	10	1.741537e-1	1.000000e+0	1.000000e+0	5.480255e+0	1.824733e-1	1	1646	5.000000e-1	6.075334e-4	unnamed	DHDDS
GO Cellular Component	GO:0031090	organelle membrane	9	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	11	2.650007e-1	1.000000e+0	1.000000e+0	3.504468e+0	2.853500e-1	1	2574	5.000000e-1	3.885004e-4	unnamed	DHDDS
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	10	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	15	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	HMGN2
GO Cellular Component	GO:0044446	intracellular organelle part	11	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	7	1.292379e-1	1.000000e+0	1.000000e+0	2.781529e+0	7.190289e-1	2	6486	1.000000e+0	3.083565e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0005634	nucleus	12	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	20	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	HMGN2
GO Cellular Component	GO:0044422	organelle part	13	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	8	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0044444	cytoplasmic part	14	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	22	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	DHDDS
GO Cellular Component	GO:0044425	membrane part	15	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	21	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	DHDDS
GO Cellular Component	GO:0016020	membrane	16	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	25	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	DHDDS
GO Cellular Component	GO:0005737	cytoplasm	17	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	12	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	18	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	13	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0043227	membrane-bounded organelle	19	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	14	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0043229	intracellular organelle	20	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	16	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0043226	organelle	21	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	17	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0044424	intracellular part	22	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	18	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0005622	intracellular	23	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	19	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0044464	cell part	24	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	23	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	DHDDS,HMGN2
GO Cellular Component	GO:0005623	cell	25	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	24	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	DHDDS,HMGN2
Human Phenotype	HP:0011505	Cystoid macular edema	1	4.564071e-5	2.805078e-1	2.805078e-1	2.191027e+4	4.564071e-5	1	4.564071e-5	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	DHDDS
Human Phenotype	HP:0001103	Abnormality of the macula	2	5.869599e-3	1.000000e+0	1.000000e+0	1.703694e+2	5.869599e-3	1	5.869599e-3	1.000000e+0	2	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	DHDDS
Human Phenotype	HP:0100689	Decreased corneal thickness	3	7.132799e-3	1.000000e+0	1.000000e+0	1.401974e+2	7.132799e-3	1	7.132799e-3	1.000000e+0	3	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	DHDDS
Human Phenotype	HP:0000842	Hyperinsulinemia	4	7.194569e-3	1.000000e+0	1.000000e+0	1.389937e+2	7.194569e-3	1	7.194569e-3	1.000000e+0	5	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	DHDDS
Human Phenotype	HP:0011486	Abnormality of corneal thickness	5	7.410583e-3	1.000000e+0	1.000000e+0	1.349422e+2	7.410583e-3	1	7.410583e-3	1.000000e+0	4	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	DHDDS
Human Phenotype	HP:0008046	Abnormality of the retinal vasculature	6	7.424132e-3	1.000000e+0	1.000000e+0	1.346959e+2	7.424132e-3	1	7.424132e-3	1.000000e+0	7	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	DHDDS
Human Phenotype	HP:0008047	Abnormality of the vasculature of the eye	7	7.843598e-3	1.000000e+0	1.000000e+0	1.274925e+2	7.843598e-3	1	7.843598e-3	1.000000e+0	9	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	DHDDS
Human Phenotype	HP:0005978	Type II diabetes mellitus	8	7.930955e-3	1.000000e+0	1.000000e+0	1.260882e+2	7.930955e-3	1	7.930955e-3	1.000000e+0	6	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	DHDDS
Human Phenotype	HP:0000662	Night blindness	9	9.351489e-3	1.000000e+0	1.000000e+0	1.069348e+2	9.351489e-3	1	9.351489e-3	1.000000e+0	11	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	DHDDS
Human Phenotype	HP:0000987	Atypical scarring of skin	10	9.492875e-3	1.000000e+0	1.000000e+0	1.053422e+2	9.492875e-3	1	9.492875e-3	1.000000e+0	8	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	DHDDS
Human Phenotype	HP:0100699	Scarring	11	9.917120e-3	1.000000e+0	1.000000e+0	1.008357e+2	9.917120e-3	1	9.917120e-3	1.000000e+0	9	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	DHDDS
Human Phenotype	HP:0000613	Photophobia	12	1.130566e-2	1.000000e+0	1.000000e+0	8.845131e+1	1.130566e-2	1	1.130566e-2	1.000000e+0	12	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	DHDDS
Human Phenotype	HP:0000512	Abnormal electroretinogram	13	1.139741e-2	1.000000e+0	1.000000e+0	8.773922e+1	1.139741e-2	1	1.139741e-2	1.000000e+0	12	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	DHDDS
Human Phenotype	HP:0000597	Ophthalmoparesis	14	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	17	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	DHDDS
Human Phenotype	HP:0003117	Abnormality of circulating hormone level	15	1.372152e-2	1.000000e+0	1.000000e+0	7.287820e+1	1.372152e-2	1	1.372152e-2	1.000000e+0	14	1.436009e-2	1.000000e+0	1.000000e+0	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	DHDDS
Human Phenotype	HP:0000819	Diabetes mellitus	16	1.619858e-2	1.000000e+0	1.000000e+0	6.173382e+1	1.619858e-2	1	1.619858e-2	1.000000e+0	18	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	DHDDS
Human Phenotype	HP:0000405	Conductive hearing impairment	17	1.627022e-2	1.000000e+0	1.000000e+0	6.146199e+1	1.627022e-2	1	1.627022e-2	1.000000e+0	15	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	DHDDS
Human Phenotype	HP:0011452	Functional abnormality of the middle ear	18	1.678248e-2	1.000000e+0	1.000000e+0	5.958595e+1	1.678248e-2	1	1.678248e-2	1.000000e+0	16	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	DHDDS
Human Phenotype	HP:0007703	Abnormal retinal pigmentation	19	1.943895e-2	1.000000e+0	1.000000e+0	5.144311e+1	1.943895e-2	1	1.943895e-2	1.000000e+0	24	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	DHDDS
Human Phenotype	HP:0000501	Glaucoma	20	2.135653e-2	1.000000e+0	1.000000e+0	4.682408e+1	2.135653e-2	1	2.135653e-2	1.000000e+0	22	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	DHDDS
Human Phenotype	HP:0008051	Abnormality of the retinal pigment epithelium	21	2.142508e-2	1.000000e+0	1.000000e+0	4.667427e+1	2.142508e-2	1	2.142508e-2	1.000000e+0	25	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	DHDDS
Human Phenotype	HP:0001513	Obesity	22	2.334050e-2	1.000000e+0	1.000000e+0	4.284398e+1	2.334050e-2	1	2.334050e-2	1.000000e+0	19	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	DHDDS
Human Phenotype	HP:0000370	Abnormality of the middle ear	23	2.356312e-2	1.000000e+0	1.000000e+0	4.243920e+1	2.356312e-2	1	2.356312e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	DHDDS
Human Phenotype	HP:0004324	Increased body weight	24	2.416288e-2	1.000000e+0	1.000000e+0	4.138580e+1	2.416288e-2	1	2.416288e-2	1.000000e+0	21	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	DHDDS
Human Phenotype	HP:0000431	Wide nasal bridge	25	2.525879e-2	1.000000e+0	1.000000e+0	3.959018e+1	2.525879e-2	1	2.525879e-2	1.000000e+0	20	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	DHDDS
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	26	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	32	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	DHDDS
Human Phenotype	HP:0000463	Anteverted nares	27	2.779733e-2	1.000000e+0	1.000000e+0	3.597468e+1	2.779733e-2	1	2.779733e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	DHDDS
Human Phenotype	HP:0001347	Hyperreflexia	28	2.789222e-2	1.000000e+0	1.000000e+0	3.585229e+1	2.789222e-2	1	2.789222e-2	1.000000e+0	35	3.428974e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	312	5.000000e-1	3.205128e-3	unnamed	DHDDS
Human Phenotype	HP:0008736	Hypoplasia of penis	29	2.837320e-2	1.000000e+0	1.000000e+0	3.524452e+1	2.837320e-2	1	2.837320e-2	1.000000e+0	23	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	DHDDS
Human Phenotype	HP:0005288	Abnormality of the nares	30	2.897002e-2	1.000000e+0	1.000000e+0	3.451844e+1	2.897002e-2	1	2.897002e-2	1.000000e+0	30	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	DHDDS
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	31	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	37	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	DHDDS
Human Phenotype	HP:0000648	Optic atrophy	32	2.952567e-2	1.000000e+0	1.000000e+0	3.386883e+1	2.952567e-2	1	2.952567e-2	1.000000e+0	33	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	DHDDS
Human Phenotype	HP:0000050	Hypoplastic genitalia	33	3.012583e-2	1.000000e+0	1.000000e+0	3.319411e+1	3.012583e-2	1	3.012583e-2	1.000000e+0	26	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	DHDDS
Human Phenotype	HP:0003241	Genital hypoplasia	34	3.063069e-2	1.000000e+0	1.000000e+0	3.264699e+1	3.063069e-2	1	3.063069e-2	1.000000e+0	29	2.577339e-2	1.000000e+0	1.000000e+0	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	DHDDS
Human Phenotype	HP:0000587	Abnormality of the optic nerve	35	3.320424e-2	1.000000e+0	1.000000e+0	3.011663e+1	3.320424e-2	1	3.320424e-2	1.000000e+0	38	3.896867e-2	1.000000e+0	1.000000e+0	2.540986e+1	3.935480e-2	1	355	5.000000e-1	2.816901e-3	unnamed	DHDDS
Human Phenotype	HP:0000429	Abnormality of the nasal alae	36	3.557102e-2	1.000000e+0	1.000000e+0	2.811277e+1	3.557102e-2	1	3.557102e-2	1.000000e+0	31	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	DHDDS
Human Phenotype	HP:0000481	Abnormality of the cornea	37	3.847321e-2	1.000000e+0	1.000000e+0	2.599211e+1	3.847321e-2	1	3.847321e-2	1.000000e+0	39	3.994654e-2	1.000000e+0	1.000000e+0	2.478159e+1	4.035253e-2	1	364	5.000000e-1	2.747253e-3	unnamed	DHDDS
Human Phenotype	HP:0010938	Abnormality of the external nose	38	3.964107e-2	1.000000e+0	1.000000e+0	2.522636e+1	3.964107e-2	1	3.964107e-2	1.000000e+0	34	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	DHDDS
Human Phenotype	HP:0000518	Cataract	39	3.983177e-2	1.000000e+0	1.000000e+0	2.510559e+1	3.983177e-2	1	3.983177e-2	1.000000e+0	40	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	DHDDS
Human Phenotype	HP:0000517	Abnormality of the lens	40	4.100359e-2	1.000000e+0	1.000000e+0	2.438811e+1	4.100359e-2	1	4.100359e-2	1.000000e+0	42	4.537010e-2	1.000000e+0	1.000000e+0	2.178865e+1	4.589546e-2	1	414	5.000000e-1	2.415459e-3	unnamed	DHDDS
Human Phenotype	HP:0000479	Abnormality of the retina	41	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	46	4.829244e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	441	5.000000e-1	2.267574e-3	unnamed	DHDDS
Human Phenotype	HP:0000036	Abnormality of the penis	42	4.249983e-2	1.000000e+0	1.000000e+0	2.352951e+1	4.249983e-2	1	4.249983e-2	1.000000e+0	36	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	DHDDS
Human Phenotype	HP:0002597	Abnormality of the vasculature	43	4.289777e-2	1.000000e+0	1.000000e+0	2.331124e+1	4.289777e-2	1	4.289777e-2	1.000000e+0	51	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	DHDDS
Human Phenotype	HP:0000505	Visual impairment	44	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	47	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	DHDDS
Human Phenotype	HP:0000407	Sensorineural hearing impairment	45	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	44	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	DHDDS
Human Phenotype	HP:0000504	Abnormality of vision	46	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	55	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	DHDDS
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	47	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	48	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	DHDDS
Human Phenotype	HP:0000359	Abnormality of the inner ear	48	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	50	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	DHDDS
Human Phenotype	HP:0000035	Abnormality of the testis	49	5.101368e-2	1.000000e+0	1.000000e+0	1.960258e+1	5.101368e-2	1	5.101368e-2	1.000000e+0	43	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	DHDDS
Human Phenotype	HP:0000639	Nystagmus	50	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	53	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	DHDDS
Human Phenotype	HP:0000022	Abnormality of male internal genitalia	51	5.264829e-2	1.000000e+0	1.000000e+0	1.899397e+1	5.264829e-2	1	5.264829e-2	1.000000e+0	45	4.775160e-2	1.000000e+0	1.000000e+0	2.068922e+1	4.833435e-2	1	436	5.000000e-1	2.293578e-3	unnamed	DHDDS
Human Phenotype	HP:0000422	Abnormality of the nasal bridge	52	5.330993e-2	1.000000e+0	1.000000e+0	1.875823e+1	5.330993e-2	1	5.330993e-2	1.000000e+0	41	4.515346e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	412	5.000000e-1	2.427184e-3	unnamed	DHDDS
Human Phenotype	HP:0005105	Abnormal nasal morphology	53	5.425388e-2	1.000000e+0	1.000000e+0	1.843186e+1	5.425388e-2	1	5.425388e-2	1.000000e+0	49	4.948174e-2	1.000000e+0	1.000000e+0	1.995686e+1	5.010809e-2	1	452	5.000000e-1	2.212389e-3	unnamed	DHDDS
Human Phenotype	HP:0000496	Abnormality of eye movement	54	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	58	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	DHDDS
Human Phenotype	HP:0000818	Abnormality of the endocrine system	55	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	60	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	DHDDS
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	56	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	61	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	DHDDS
Human Phenotype	HP:0000032	Abnormality of male external genitalia	57	5.856997e-2	1.000000e+0	1.000000e+0	1.707359e+1	5.856997e-2	1	5.856997e-2	1.000000e+0	52	5.207398e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	476	5.000000e-1	2.100840e-3	unnamed	DHDDS
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	58	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	62	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	DHDDS
Human Phenotype	HP:0001098	Abnormality of the fundus	59	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	62	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	DHDDS
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	60	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	64	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	DHDDS
Human Phenotype	HP:0000811	Abnormal external genitalia	61	5.948677e-2	1.000000e+0	1.000000e+0	1.681046e+1	5.948677e-2	1	5.948677e-2	1.000000e+0	54	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	DHDDS
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	62	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	58	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	DHDDS
Human Phenotype	HP:0010461	Abnormality of the male genitalia	63	6.153041e-2	1.000000e+0	1.000000e+0	1.625213e+1	6.153041e-2	1	6.153041e-2	1.000000e+0	56	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	DHDDS
Human Phenotype	HP:0004323	Abnormality of body weight	64	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	64	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	DHDDS
Human Phenotype	HP:0000812	Abnormal internal genitalia	65	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	57	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	DHDDS
Human Phenotype	HP:0004328	Abnormality of the anterior segment of the eye	66	6.610995e-2	1.000000e+0	1.000000e+0	1.512632e+1	6.610995e-2	1	6.610995e-2	1.000000e+0	67	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	DHDDS
Human Phenotype	HP:0003549	Abnormality of connective tissue	67	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	67	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	DHDDS
Human Phenotype	HP:0012243	Abnormal genital system morphology	68	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	66	6.712488e-2	1.000000e+0	1.000000e+0	1.464367e+1	6.828890e-2	1	616	5.000000e-1	1.623377e-3	unnamed	DHDDS
Human Phenotype	HP:0000365	Hearing impairment	69	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	69	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	DHDDS
Human Phenotype	HP:0000364	Hearing abnormality	70	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	70	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	DHDDS
Human Phenotype	HP:0000078	Abnormality of the genital system	71	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	71	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	DHDDS
Human Phenotype	HP:0011354	Generalized abnormality of skin	72	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	74	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	DHDDS
Human Phenotype	HP:0011442	Abnormality of central motor function	73	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	73	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	DHDDS
Human Phenotype	HP:0000366	Abnormality of the nose	74	8.197813e-2	1.000000e+0	1.000000e+0	1.219838e+1	8.197813e-2	1	8.197813e-2	1.000000e+0	72	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	DHDDS
Human Phenotype	HP:0000951	Abnormality of the skin	75	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	76	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	DHDDS
Human Phenotype	HP:0000598	Abnormality of the ear	76	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	75	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	DHDDS
Human Phenotype	HP:0012373	Abnormal eye physiology	77	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	78	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	DHDDS
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	78	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	77	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	DHDDS
Human Phenotype	HP:0012374	Abnormality of the globe	79	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	79	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	DHDDS
Human Phenotype	HP:0012372	Abnormal eye morphology	80	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	81	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	DHDDS
Human Phenotype	HP:0001507	Growth abnormality	81	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	80	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	DHDDS
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	82	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	82	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	DHDDS
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	83	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	87	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	DHDDS
Human Phenotype	HP:0001574	Abnormality of the integument	84	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	83	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	DHDDS
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	85	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	84	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	DHDDS
Human Phenotype	HP:0100543	Cognitive impairment	86	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	85	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	DHDDS
Human Phenotype	HP:0000271	Abnormality of the face	87	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	86	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	DHDDS
Human Phenotype	HP:0000007	Autosomal recessive inheritance	88	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	92	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	DHDDS
Human Phenotype	HP:0000478	Abnormality of the eye	89	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	88	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	DHDDS
Human Phenotype	HP:0011446	Abnormality of higher mental function	90	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	89	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	DHDDS
Human Phenotype	HP:0000234	Abnormality of the head	91	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	90	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	DHDDS
Human Phenotype	HP:0000152	Abnormality of head and neck	92	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	91	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	DHDDS
Human Phenotype	HP:0002011	Abnormality of the central nervous system	93	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	93	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	DHDDS
Human Phenotype	HP:0000707	Abnormality of the nervous system	94	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	94	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	DHDDS
Human Phenotype	HP:0000005	Mode of inheritance	95	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	95	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	DHDDS
Human Phenotype	HP:0000118	Phenotypic abnormality	96	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	96	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	DHDDS
Human Phenotype	HP:0000001	All	97	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	97	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	DHDDS
Disease Ontology	DOID:10584	retinitis pigmentosa	1	6.647729e-3	1.000000e+0	1.000000e+0	1.504273e+2	6.647729e-3	1	6.647729e-3	1.000000e+0	1	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	DHDDS
Disease Ontology	DOID:3612	retinitis	2	7.455033e-3	1.000000e+0	1.000000e+0	1.341376e+2	7.455033e-3	1	7.455033e-3	1.000000e+0	2	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	DHDDS
Disease Ontology	DOID:8466	retinal degeneration	3	2.566578e-2	1.000000e+0	1.000000e+0	3.896239e+1	2.566578e-2	1	2.566578e-2	1.000000e+0	3	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	DHDDS
Disease Ontology	DOID:5679	retinal disease	4	4.769824e-2	1.000000e+0	1.000000e+0	2.096514e+1	4.769824e-2	1	4.769824e-2	1.000000e+0	4	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	DHDDS
Disease Ontology	DOID:5614	eye disease	5	6.845790e-2	1.000000e+0	1.000000e+0	1.460752e+1	6.845790e-2	1	6.845790e-2	1.000000e+0	5	6.883732e-2	1.000000e+0	1.000000e+0	1.427294e+1	7.006264e-2	1	632	5.000000e-1	1.582278e-3	unnamed	DHDDS
Disease Ontology	DOID:0050155	sensory system disease	6	7.608032e-2	1.000000e+0	1.000000e+0	1.314400e+1	7.608032e-2	1	7.608032e-2	1.000000e+0	6	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	DHDDS
Disease Ontology	DOID:863	nervous system disease	7	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	7	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	DHDDS
Disease Ontology	DOID:7	disease of anatomical entity	8	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	8	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	DHDDS
Disease Ontology	DOID:4	disease	9	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	9	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	DHDDS
MSigDB Cancer Neighborhood	GCM_ANP32B	Neighborhood of ANP32B	1	1.680931e-3	7.177575e-1	7.177575e-1	5.949085e+2	1.680931e-3	1	1.680931e-3	1.000000e+0	1	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	HMGN2
MSigDB Cancer Neighborhood	GNF2_ANP32B	Neighborhood of ANP32B	2	2.698677e-3	1.000000e+0	5.761675e-1	3.705520e+2	2.698677e-3	1	2.698677e-3	1.000000e+0	2	4.097676e-3	1.000000e+0	8.748538e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	HMGN2
MSigDB Cancer Neighborhood	GNF2_APEX1	Neighborhood of APEX1	3	5.707614e-3	1.000000e+0	8.123837e-1	1.752045e+2	5.707614e-3	1	5.707614e-3	1.000000e+0	3	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	HMGN2
MSigDB Cancer Neighborhood	GCM_ACTG1	Neighborhood of ACTG1	4	6.294877e-3	1.000000e+0	6.719781e-1	1.588593e+2	6.294877e-3	1	6.294877e-3	1.000000e+0	4	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	HMGN2
MSigDB Cancer Neighborhood	MORF_ACTG1	Neighborhood of ACTG1	5	7.322064e-3	1.000000e+0	6.253043e-1	1.365735e+2	7.322064e-3	1	7.322064e-3	1.000000e+0	5	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	HMGN2
MSigDB Cancer Neighborhood	MORF_NME2	Neighborhood of NME2	6	7.465373e-3	1.000000e+0	5.312857e-1	1.339518e+2	7.465373e-3	1	7.465373e-3	1.000000e+0	6	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	HMGN2
MSigDB Cancer Neighborhood	MORF_NPM1	Neighborhood of NPM1	7	8.889062e-3	1.000000e+0	5.422328e-1	1.124978e+2	8.889062e-3	1	8.889062e-3	1.000000e+0	7	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	HMGN2
BioCyc Pathway	PWY-6129	dolichol and dolichyl phosphate biosynthesis	1	1.210338e-4	4.018322e-2	4.018322e-2	8.262154e+3	1.210338e-4	1	1.210338e-4	1.000000e+0	1	3.325574e-4	1.104091e-1	1.104091e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	DHDDS
MSigDB Pathway	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	Terpenoid backbone biosynthesis	1	1.041769e-3	1.000000e+0	1.000000e+0	9.599053e+2	1.041769e-3	1	1.041769e-3	1.000000e+0	1	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	DHDDS
MSigDB Perturbation	LY_AGING_MIDDLE_DN	Genes down-regulated in fibroblasts from middle-age individuals, compared to those from the young donors.	1	6.943343e-4	1.000000e+0	1.000000e+0	1.440228e+3	6.943343e-4	1	6.943343e-4	1.000000e+0	2	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	HMGN2
MSigDB Perturbation	MANN_RESPONSE_TO_AMIFOSTINE_DN	Genes down-regulated in HCT116 cells (colon cancer) after treatment with amifostine [PubChem=2141] depending on the presence of TP53 [GeneID=7157]: TP53-positive vs TP53-null cells.	2	1.048562e-3	1.000000e+0	1.000000e+0	9.536871e+2	1.048562e-3	1	1.048562e-3	1.000000e+0	1	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	HMGN2
MSigDB Perturbation	LY_AGING_PREMATURE_DN	Genes down-regulated in fibroblasts from patients with Hutchinson-Gilford progeria (premature aging), compared to those from normal young individuals.	3	2.216999e-3	1.000000e+0	1.000000e+0	4.510601e+2	2.216999e-3	1	2.216999e-3	1.000000e+0	3	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	HMGN2
MSigDB Perturbation	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	Genes down-regulated in A172 cells (glioma, does not express MGMT [GeneID=4255]) by carmustine [PubChem=2578] at 48 h.	4	2.511987e-3	1.000000e+0	1.000000e+0	3.980912e+2	2.511987e-3	1	2.511987e-3	1.000000e+0	3	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	HMGN2
MSigDB Perturbation	DORSAM_HOXA9_TARGETS_UP	HOXA9 [GeneID=3205] targets up-regulated in hematopoietic stem cells.	5	2.927778e-3	1.000000e+0	1.000000e+0	3.415560e+2	2.927778e-3	1	2.927778e-3	1.000000e+0	5	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	HMGN2
MSigDB Perturbation	SESTO_RESPONSE_TO_UV_C6	Cluster 6: genes changed in primary keratinocytes by UVB irradiation.	6	3.013965e-3	1.000000e+0	1.000000e+0	3.317889e+2	3.013965e-3	1	3.013965e-3	1.000000e+0	6	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	HMGN2
MSigDB Perturbation	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	Genes up-regulated by 2-methoxyestradiol (2ME2) [PubChem=1573] in the MM.1S cell line (multiple myeloma) sensitive to dexamethasone [PubChem=5743].	7	3.174998e-3	1.000000e+0	1.000000e+0	3.149608e+2	3.174998e-3	1	3.174998e-3	1.000000e+0	7	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	HMGN2
MSigDB Perturbation	TONG_INTERACT_WITH_PTTG1	Proteins that interact with PTTG1 [GeneID=9232], based on protein array.	8	3.901429e-3	1.000000e+0	1.000000e+0	2.563163e+2	3.901429e-3	1	3.901429e-3	1.000000e+0	8	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	HMGN2
MSigDB Perturbation	LY_AGING_OLD_DN	Genes down-regulated in fibroblasts from old individuals, compared to those from young donors.	9	5.480074e-3	1.000000e+0	1.000000e+0	1.824793e+2	5.480074e-3	1	5.480074e-3	1.000000e+0	9	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	HMGN2
MSigDB Perturbation	MORI_PRE_BI_LYMPHOCYTE_UP	Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the Pre-BI stage.	10	5.997622e-3	1.000000e+0	1.000000e+0	1.667327e+2	5.997622e-3	1	5.997622e-3	1.000000e+0	10	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	HMGN2
MSigDB Perturbation	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	Top 100 genes negatively associated with T-cell acute lymphoblastic leukemia MLL T-ALL) expressing MLL-ENL fusion [GeneID=4297;4298].	11	6.941033e-3	1.000000e+0	1.000000e+0	1.440708e+2	6.941033e-3	1	6.941033e-3	1.000000e+0	13	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	HMGN2
MSigDB Perturbation	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the  Large Pre-BII stage.	12	7.389724e-3	1.000000e+0	1.000000e+0	1.353230e+2	7.389724e-3	1	7.389724e-3	1.000000e+0	11	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	HMGN2
MSigDB Perturbation	MORI_IMMATURE_B_LYMPHOCYTE_DN	Down-regulated genes in the B lymphocyte developmental signature based on expression profiling of lymphomas from the Emu-myc transgenic mice: the immature B stage.	13	7.715653e-3	1.000000e+0	1.000000e+0	1.296067e+2	7.715653e-3	1	7.715653e-3	1.000000e+0	12	1.028356e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	HMGN2
MSigDB Perturbation	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	'Cancer prone response profile' (CPRP): genes common to estradiol and bisphenol A [PubChem=5757;6623]  response of epithelial cell cultures from patients at high risk of breast cancer.	14	8.392036e-3	1.000000e+0	1.000000e+0	1.191606e+2	8.392036e-3	1	8.392036e-3	1.000000e+0	14	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	HMGN2
MSigDB Perturbation	JIANG_VHL_TARGETS	Genes up-regulated in 786-0 cells (renal carcinoma, RCC) upon expression of VHL [GeneID=7428] off a retroviral vector under normoxia (normal oxygen) condition.	15	9.735569e-3	1.000000e+0	1.000000e+0	1.027161e+2	9.735569e-3	1	9.735569e-3	1.000000e+0	16	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	HMGN2
MSigDB Perturbation	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	Genes down-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].	16	1.026235e-2	1.000000e+0	1.000000e+0	9.744355e+1	1.026235e-2	1	1.026235e-2	1.000000e+0	14	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	HMGN2
MSigDB Perturbation	FERNANDEZ_BOUND_BY_MYC	Genes identified by ChIP within the high-affinity group of MYC [GeneID=4609] targets.	17	1.164859e-2	1.000000e+0	1.000000e+0	8.584729e+1	1.164859e-2	1	1.164859e-2	1.000000e+0	21	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	HMGN2
MSigDB Perturbation	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	Genes down-regulated in T98G cells (glioma, express MGMT [GeneID=4255]) by carmustine [PubChem=2578] at 48 h.	18	1.179116e-2	1.000000e+0	1.000000e+0	8.480928e+1	1.179116e-2	1	1.179116e-2	1.000000e+0	17	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	HMGN2
MSigDB Perturbation	BENPORATH_MYC_TARGETS_WITH_EBOX	Set 'Myc targets1': targets of c-Myc [GeneID=4609] identified by ChIP on chip in cultured cell lines, focusing on E-box-containing genes; high affinity bound subset	19	1.387680e-2	1.000000e+0	1.000000e+0	7.206271e+1	1.387680e-2	1	1.387680e-2	1.000000e+0	27	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	HMGN2
MSigDB Perturbation	CHANG_CORE_SERUM_RESPONSE_UP	Up-regulated genes in the canonical gene expression signature of the fibroblast core serum response (CSR) defined by the Stanford group.	20	1.461864e-2	1.000000e+0	1.000000e+0	6.840583e+1	1.461864e-2	1	1.461864e-2	1.000000e+0	23	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	HMGN2
MSigDB Perturbation	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	Genes up-regulated in genomically unstable Ewing's sarcoma tumors compared to the stable ones.	21	1.520323e-2	1.000000e+0	1.000000e+0	6.577549e+1	1.520323e-2	1	1.520323e-2	1.000000e+0	17	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	HMGN2
MSigDB Perturbation	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	Genes not induced under hypoxia, but dependent on KDM3A [GeneID=55818] for hypoxic expression in RCC4 cells (renal carcinoma) expressing VHL [GeneID=7428].	22	1.630707e-2	1.000000e+0	1.000000e+0	6.132311e+1	1.630707e-2	1	1.630707e-2	1.000000e+0	22	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	HMGN2
MSigDB Perturbation	LINSLEY_MIR16_TARGETS	Transcripts down-regulated by overexpression of MIR16 family of microRNA molecules in DLD-1 and HCT116 (colon cancer) cells hypomorphic for DICER1 [GeneID=23405].	23	1.715535e-2	1.000000e+0	1.000000e+0	5.829085e+1	1.715535e-2	1	1.715535e-2	1.000000e+0	23	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	DHDDS
MSigDB Perturbation	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	Down-regulated genes whose expression correlates with copy number losses in pancreatic adenocarcinoma cell lines and primary tumor specimens.	24	1.824244e-2	1.000000e+0	1.000000e+0	5.481722e+1	1.824244e-2	1	1.824244e-2	1.000000e+0	26	2.511674e-2	1.000000e+0	1.000000e+0	3.956360e+1	2.527576e-2	1	228	5.000000e-1	4.385965e-3	unnamed	HMGN2
MSigDB Perturbation	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	Genes down-regulated by 3 h of euglycemic hyperinsulinemic clamp in the vastus lateralis muscle of healthy lean subjects.	25	1.996880e-2	1.000000e+0	1.000000e+0	5.007812e+1	1.996880e-2	1	1.996880e-2	1.000000e+0	19	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	DHDDS
MSigDB Perturbation	HSIAO_HOUSEKEEPING_GENES	Housekeeping genes identified as expressed across 19 normal tissues.	26	2.209482e-2	1.000000e+0	1.000000e+0	4.525947e+1	2.209482e-2	1	2.209482e-2	1.000000e+0	33	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	HMGN2
MSigDB Perturbation	KARLSSON_TGFB1_TARGETS_DN	Genes down-regulated by TGFB1 [GeneID=7040] in MEF cells (embryonic fibroblast) via TGFB1R [GeneID=7046].	27	2.417575e-2	1.000000e+0	1.000000e+0	4.136376e+1	2.417575e-2	1	2.417575e-2	1.000000e+0	25	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	HMGN2
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	28	2.574991e-2	1.000000e+0	1.000000e+0	3.883509e+1	2.574991e-2	1	2.574991e-2	1.000000e+0	29	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	HMGN2
MSigDB Perturbation	BENPORATH_NOS_TARGETS	Set 'NOS targets': genes upregulated and identified by ChIP on chip as targets of the transcription factors NANOG , OCT4, and Sox2 [GeneID=79923;5460;6657] (NOS) in human embryonic stem cells.	29	2.851793e-2	1.000000e+0	1.000000e+0	3.506566e+1	2.851793e-2	1	2.851793e-2	1.000000e+0	20	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	DHDDS
MSigDB Perturbation	STEIN_ESRRA_TARGETS_UP	Genes up-regulated by ESRRA [GeneID=2101] only.	30	3.184050e-2	1.000000e+0	1.000000e+0	3.140654e+1	3.184050e-2	1	3.184050e-2	1.000000e+0	32	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	DHDDS
MSigDB Perturbation	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	Genes down-regulated in ALL (acute lymphoblastic leukemia) blasts after 1 week of treatment with glucocorticoids.	31	3.771906e-2	1.000000e+0	1.000000e+0	2.651180e+1	3.771906e-2	1	3.771906e-2	1.000000e+0	31	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	HMGN2
MSigDB Perturbation	MARTENS_TRETINOIN_RESPONSE_DN	Genes down-regulated in NB4 cells (acute promyelocytic leukemia, APL) in response to tretinoin [PubChem=444795]; based on Chip-seq data.	32	3.772631e-2	1.000000e+0	1.000000e+0	2.650670e+1	3.772631e-2	1	3.772631e-2	1.000000e+0	42	8.449668e-2	1.000000e+0	1.000000e+0	1.157959e+1	8.635885e-2	1	779	5.000000e-1	1.283697e-3	unnamed	HMGN2
MSigDB Perturbation	KOYAMA_SEMA3B_TARGETS_DN	Genes down-regulated in NCI-H1299 cells (large cell neuroendocrine carcinoma) stably expressing SEMA3B [GeneID=7869].	33	4.388800e-2	1.000000e+0	1.000000e+0	2.278527e+1	4.388800e-2	1	4.388800e-2	1.000000e+0	30	4.103249e-2	1.000000e+0	1.000000e+0	2.411898e+1	4.146112e-2	1	374	5.000000e-1	2.673797e-3	unnamed	HMGN2
MSigDB Perturbation	BENPORATH_OCT4_TARGETS	Set 'Oct4 targets': genes upregulated and identified by ChIP on chip as OCT4 [GeneID=5460] transcription factor targets in human embryonic stem cells.	34	4.396975e-2	1.000000e+0	1.000000e+0	2.274291e+1	4.396975e-2	1	4.396975e-2	1.000000e+0	28	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	DHDDS
MSigDB Perturbation	STEIN_ESRRA_TARGETS	Genes regulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	35	4.591289e-2	1.000000e+0	1.000000e+0	2.178037e+1	4.591289e-2	1	4.591289e-2	1.000000e+0	34	5.724786e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	DHDDS
MSigDB Perturbation	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	Genes with copy number losses in primary neuroblastoma tumors.	36	5.143070e-2	1.000000e+0	1.000000e+0	1.944364e+1	5.143070e-2	1	5.143070e-2	1.000000e+0	39	8.035509e-2	1.000000e+0	1.000000e+0	1.218986e+1	8.203536e-2	1	740	5.000000e-1	1.351351e-3	unnamed	DHDDS
MSigDB Perturbation	FEVR_CTNNB1_TARGETS_DN	Genes down-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	37	5.544406e-2	1.000000e+0	1.000000e+0	1.803620e+1	5.544406e-2	1	5.544406e-2	1.000000e+0	36	5.950698e-2	1.000000e+0	1.000000e+0	1.655138e+1	6.041794e-2	1	545	5.000000e-1	1.834862e-3	unnamed	HMGN2
MSigDB Perturbation	CHICAS_RB1_TARGETS_SENESCENT	Genes up-regulated in senescent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	38	5.829074e-2	1.000000e+0	1.000000e+0	1.715538e+1	5.829074e-2	1	5.829074e-2	1.000000e+0	35	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	HMGN2
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	39	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	43	8.608710e-2	1.000000e+0	1.000000e+0	1.136083e+1	8.802173e-2	1	794	5.000000e-1	1.259446e-3	unnamed	HMGN2
MSigDB Perturbation	PATIL_LIVER_CANCER	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	40	5.982431e-2	1.000000e+0	1.000000e+0	1.671561e+1	5.982431e-2	1	5.982431e-2	1.000000e+0	37	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	HMGN2
MSigDB Perturbation	LOPEZ_MBD_TARGETS	Genes up-regulated in HeLa cells (cervical cancer) after simultaneus knockdown of all three MBD (methyl-CpG binding domain) proteins MeCP2, MBD1 and MBD2 [GeneID=4204;4152;8932] by RNAi.	41	6.397820e-2	1.000000e+0	1.000000e+0	1.563032e+1	6.397820e-2	1	6.397820e-2	1.000000e+0	44	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	HMGN2
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	42	6.489857e-2	1.000000e+0	1.000000e+0	1.540866e+1	6.489857e-2	1	6.489857e-2	1.000000e+0	40	8.099287e-2	1.000000e+0	1.000000e+0	1.209182e+1	8.270052e-2	1	746	5.000000e-1	1.340483e-3	unnamed	DHDDS
MSigDB Perturbation	FORTSCHEGGER_PHF8_TARGETS_DN	Genes down-regulated in HeLa cells (cervical carcinoma) upon knockdown of PHF8 [GeneID=23133] by RNAi.	43	7.444945e-2	1.000000e+0	1.000000e+0	1.343193e+1	7.444945e-2	1	7.444945e-2	1.000000e+0	41	8.109914e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	HMGN2
MSigDB Perturbation	BENPORATH_SOX2_TARGETS	Set 'Sox2 targets': genes upregulated and identified by ChIP on chip as SOX2 [GeneID=6657] transcription factor targets in human embryonic stem cells.	44	7.617690e-2	1.000000e+0	1.000000e+0	1.312734e+1	7.617690e-2	1	7.617690e-2	1.000000e+0	37	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	DHDDS
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	45	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	46	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	HMGN2
MSigDB Perturbation	BENPORATH_NANOG_TARGETS	Set 'Nanog targets': genes upregulated and identified by ChIP on chip as Nanog [GeneID=79923] transcription factor targets in human embryonic stem cells.	46	1.005508e-1	1.000000e+0	1.000000e+0	9.945225e+0	1.005508e-1	1	1.005508e-1	1.000000e+0	45	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	DHDDS
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	47	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	47	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	HMGN2
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	48	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	48	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	HMGN2
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	Genes down-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	49	1.826173e-1	1.000000e+0	1.000000e+0	5.475932e+0	1.826173e-1	1	1.826173e-1	1.000000e+0	49	1.827952e-1	1.000000e+0	1.000000e+0	5.208141e+0	1.920071e-1	1	1732	5.000000e-1	5.773672e-4	unnamed	DHDDS
MSigDB Predicted Promoter Motifs	MCAATNNNNNGCG_UNKNOWN	Motif MCAATNNNNNGCG (no known TF)	1	9.167539e-3	1.000000e+0	1.000000e+0	1.090805e+2	9.167539e-3	1	9.167539e-3	1.000000e+0	2	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$PPARA_02	Motif NNRGGTCATWGGGGTSANG matches PPARA: peroxisome proliferative activated receptor, alpha	2	9.647670e-3	1.000000e+0	1.000000e+0	1.036520e+2	9.647670e-3	1	9.647670e-3	1.000000e+0	6	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$EGR3_01	Motif NTGCGTGGGCGK matches EGR3: early growth response 3	3	9.934737e-3	1.000000e+0	1.000000e+0	1.006569e+2	9.934737e-3	1	9.934737e-3	1.000000e+0	3	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$HTF_01	Motif NNWWWWNGMCACGTCATYNYWNNN (no known TF)	4	1.004916e-2	1.000000e+0	1.000000e+0	9.951080e+1	1.004916e-2	1	1.004916e-2	1.000000e+0	1	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	DHDDS
MSigDB Predicted Promoter Motifs	GGCNKCCATNK_UNKNOWN	Motif GGCNKCCATNK (no known TF)	5	1.013812e-2	1.000000e+0	1.000000e+0	9.863765e+1	1.013812e-2	1	1.013812e-2	1.000000e+0	5	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$ETF_Q6	Motif GVGGMGG (no known TF)	6	1.113405e-2	1.000000e+0	1.000000e+0	8.981458e+1	1.113405e-2	1	1.113405e-2	1.000000e+0	4	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MYC_Q2	Motif CACGTGS matches MYC: v-myc myelocytomatosis viral oncogene homolog (avian)	7	1.125728e-2	1.000000e+0	9.890325e-1	8.883141e+1	1.125728e-2	1	1.125728e-2	1.000000e+0	11	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MAZ_Q6	Motif GGGGAGGG matches MAZ: MYC-associated zinc finger protein (purine-binding transcription factor)	8	1.383398e-2	1.000000e+0	1.000000e+0	7.228579e+1	1.383398e-2	1	1.383398e-2	1.000000e+0	12	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q2	Motif GGCGSG matches E2F&lt;br&gt; TFDP1: transcription factor Dp-1	9	1.628340e-2	1.000000e+0	1.000000e+0	6.141224e+1	1.628340e-2	1	1.628340e-2	1.000000e+0	9	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$XBP1_01	Motif NNGNTGACGTGKNNNWT matches XBP1: X-box binding protein 1	10	1.661986e-2	1.000000e+0	1.000000e+0	6.016897e+1	1.661986e-2	1	1.661986e-2	1.000000e+0	7	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	DHDDS
MSigDB Predicted Promoter Motifs	V$USF2_Q6	Motif CASGYG (no known TF)	11	1.739327e-2	1.000000e+0	9.724419e-1	5.749349e+1	1.739327e-2	1	1.739327e-2	1.000000e+0	44	2.686732e-2	1.000000e+0	3.755319e-1	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$USF_Q6	Motif GYCACGTGNC (no known TF)	12	1.944634e-2	1.000000e+0	9.966249e-1	5.142355e+1	1.944634e-2	1	1.944634e-2	1.000000e+0	47	2.719538e-2	1.000000e+0	3.558544e-1	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$TEF1_Q6	Motif GRRATG (no known TF)	13	1.954197e-2	1.000000e+0	9.244855e-1	5.117192e+1	1.954197e-2	1	1.954197e-2	1.000000e+0	16	2.369323e-2	1.000000e+0	9.107085e-1	4.195581e+1	2.383460e-2	1	215	5.000000e-1	4.651163e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$USF_01	Motif NNRYCACGTGRYNN (no known TF)	14	1.973798e-2	1.000000e+0	8.670613e-1	5.066374e+1	1.973798e-2	1	1.973798e-2	1.000000e+0	42	2.675795e-2	1.000000e+0	3.918128e-1	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$USF_Q6_01	Motif NRCCACGTGASN (no known TF)	15	2.023801e-2	1.000000e+0	8.297584e-1	4.941197e+1	2.023801e-2	1	2.023801e-2	1.000000e+0	21	2.489780e-2	1.000000e+0	7.291499e-1	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F1DP1RB_01	Motif TTTSGCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1&lt;br&gt; RB1: retinoblastoma 1 (including osteosarcoma)	16	2.030172e-2	1.000000e+0	7.803474e-1	4.925690e+1	2.030172e-2	1	2.030172e-2	1.000000e+0	24	2.522619e-2	1.000000e+0	6.464211e-1	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	WWTAAGGC_UNKNOWN	Motif WWTAAGGC (no known TF)	17	2.034194e-2	1.000000e+0	7.358996e-1	4.915951e+1	2.034194e-2	1	2.034194e-2	1.000000e+0	8	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F1_Q6_01	Motif NTTTCGCGCS matches E2F1: E2F transcription factor 1	18	2.079478e-2	1.000000e+0	7.104883e-1	4.808899e+1	2.079478e-2	1	2.079478e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	5.820754e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q6	Motif TTTSGCGS (no known TF)	19	2.155031e-2	1.000000e+0	6.975495e-1	4.640305e+1	2.155031e-2	1	2.155031e-2	1.000000e+0	61	2.785133e-2	1.000000e+0	2.807962e-1	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q4	Motif TTTSGCGS (no known TF)	20	2.157092e-2	1.000000e+0	6.633058e-1	4.635871e+1	2.157092e-2	1	2.157092e-2	1.000000e+0	32	2.566396e-2	1.000000e+0	4.932292e-1	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$EGR2_01	Motif NTGCGTRGGCGK matches EGR2: early growth response 2 (Krox-20 homolog, Drosophila)	21	2.209163e-2	1.000000e+0	6.469692e-1	4.526600e+1	2.209163e-2	1	2.209163e-2	1.000000e+0	13	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q3	Motif TTTCGCGC (no known TF)	22	2.239629e-2	1.000000e+0	6.260781e-1	4.465026e+1	2.239629e-2	1	2.239629e-2	1.000000e+0	20	2.456936e-2	1.000000e+0	7.555078e-1	4.045067e+1	2.472147e-2	1	223	5.000000e-1	4.484305e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F1_Q3	Motif NKTSSCGC matches E2F1: E2F transcription factor 1	23	2.249982e-2	1.000000e+0	6.016256e-1	4.444481e+1	2.249982e-2	1	2.249982e-2	1.000000e+0	36	2.653920e-2	1.000000e+0	4.533780e-1	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$ARNT_01	Motif NDDNNCACGTGNNNNN matches ARNT: aryl hydrocarbon receptor nuclear translocator	24	2.283069e-2	1.000000e+0	5.850364e-1	4.380070e+1	2.283069e-2	1	2.283069e-2	1.000000e+0	42	2.675795e-2	1.000000e+0	3.918128e-1	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$AP4_Q6	Motif CWCAGCTGGN matches TFAP4: transcription factor AP-4 (activating enhancer binding protein 4)	25	2.314413e-2	1.000000e+0	5.693456e-1	4.320750e+1	2.314413e-2	1	2.314413e-2	1.000000e+0	17	2.391230e-2	1.000000e+0	8.650626e-1	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q4_01	Motif NCSCGCSAAAN matches E2F&lt;br&gt; TFDP1: transcription factor Dp-1	26	2.319351e-2	1.000000e+0	5.486157e-1	4.311552e+1	2.319351e-2	1	2.319351e-2	1.000000e+0	23	2.511674e-2	1.000000e+0	6.715998e-1	3.956360e+1	2.527576e-2	1	228	5.000000e-1	4.385965e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_03	Motif TTTSGCGCGMNR (no known TF)	27	2.329859e-2	1.000000e+0	5.306901e-1	4.292106e+1	2.329859e-2	1	2.329859e-2	1.000000e+0	36	2.653920e-2	1.000000e+0	4.533780e-1	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$LBP1_Q6	Motif CAGCTGS matches UBP1: upstream binding protein 1 (LBP-1a)	28	2.342116e-2	1.000000e+0	5.144291e-1	4.269642e+1	2.342116e-2	1	2.342116e-2	1.000000e+0	15	2.336458e-2	1.000000e+0	9.579478e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$NERF_Q2	Motif YRNCAGGAAGYRNSTBDS matches ELF2: E74-like factor 2 (ets domain transcription factor)	29	2.390919e-2	1.000000e+0	5.070397e-1	4.182491e+1	2.390919e-2	1	2.390919e-2	1.000000e+0	40	2.664858e-2	1.000000e+0	4.097219e-1	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F1_Q4_01	Motif TTTSGCGSG matches E2F&lt;br&gt; TFDP1: transcription factor Dp-1	30	2.394050e-2	1.000000e+0	4.907803e-1	4.177023e+1	2.394050e-2	1	2.394050e-2	1.000000e+0	24	2.522619e-2	1.000000e+0	6.464211e-1	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q6_01	Motif NKCGCGCSAAAN matches E2F&lt;br&gt; TFDP1: transcription factor Dp-1	31	2.408749e-2	1.000000e+0	4.778647e-1	4.151533e+1	2.408749e-2	1	2.408749e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	5.820754e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MYOGENIN_Q6	Motif RGCAGSTG matches MYOG: myogenin (myogenic factor 4)	32	2.431901e-2	1.000000e+0	4.673810e-1	4.112010e+1	2.431901e-2	1	2.431901e-2	1.000000e+0	36	2.653920e-2	1.000000e+0	4.533780e-1	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F1_Q4	Motif NTTSGCGG matches E2F1: E2F transcription factor 1	33	2.463535e-2	1.000000e+0	4.591133e-1	4.059207e+1	2.463535e-2	1	2.463535e-2	1.000000e+0	32	2.566396e-2	1.000000e+0	4.932292e-1	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F_Q3_01	Motif TTTSGCGSG matches E2F&lt;br&gt; TFDP1: transcription factor Dp-1	34	2.555372e-2	1.000000e+0	4.622217e-1	3.913324e+1	2.555372e-2	1	2.555372e-2	1.000000e+0	34	2.599222e-2	1.000000e+0	4.701534e-1	3.822246e+1	2.616263e-2	1	236	5.000000e-1	4.237288e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$NFY_Q6_01	Motif NNNNRRCCAATSR (no known TF)	35	2.596576e-2	1.000000e+0	4.562555e-1	3.851225e+1	2.596576e-2	1	2.596576e-2	1.000000e+0	73	3.134601e-2	1.000000e+0	2.640794e-1	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$SP1_01	Motif GGGGCGGGGT matches SP1: Sp1 transcription factor	36	2.637734e-2	1.000000e+0	4.506129e-1	3.791133e+1	2.637734e-2	1	2.637734e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	5.820754e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$RFX1_02	Motif NNGTNRCNATRGYAACNN matches RFX1: regulatory factor X, 1 (influences HLA class II expression)	37	2.639994e-2	1.000000e+0	4.388098e-1	3.787888e+1	2.639994e-2	1	2.639994e-2	1.000000e+0	65	2.828851e-2	1.000000e+0	2.676528e-1	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$SPZ1_01	Motif DNNGGRGGGWWNNNN matches SPZ1: spermatogenic leucine zipper 1	38	2.648023e-2	1.000000e+0	4.285616e-1	3.776402e+1	2.648023e-2	1	2.648023e-2	1.000000e+0	22	2.500727e-2	1.000000e+0	6.990669e-1	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$HIF1_Q3	Motif GNNKACGTGCGGNN matches HIF1A: hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	39	2.651518e-2	1.000000e+0	4.181240e-1	3.771425e+1	2.651518e-2	1	2.651518e-2	1.000000e+0	19	2.435036e-2	1.000000e+0	7.881827e-1	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MYOD_Q6_01	Motif CNGNRNCAGGTGNNGNAN matches MYOD1: myogenic differentiation 1	40	2.651834e-2	1.000000e+0	4.077195e-1	3.770975e+1	2.651834e-2	1	2.651834e-2	1.000000e+0	36	2.653920e-2	1.000000e+0	4.533780e-1	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$USF_C	Motif NCACGTGN (no known TF)	41	2.667910e-2	1.000000e+0	4.001865e-1	3.748252e+1	2.667910e-2	1	2.667910e-2	1.000000e+0	70	2.927180e-2	1.000000e+0	2.571737e-1	3.391165e+1	2.948839e-2	1	266	5.000000e-1	3.759398e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$NMYC_01	Motif NNCCACGTGNNN matches MYCN: v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)	42	2.675365e-2	1.000000e+0	3.917499e-1	3.737808e+1	2.675365e-2	1	2.675365e-2	1.000000e+0	65	2.828851e-2	1.000000e+0	2.676528e-1	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$HEB_Q6	Motif RCCWGCTG matches TCF12: transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)	43	2.710963e-2	1.000000e+0	3.877308e-1	3.688726e+1	2.710963e-2	1	2.710963e-2	1.000000e+0	69	2.883484e-2	1.000000e+0	2.570062e-1	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$HIF1_Q5	Motif CGTACGTGCNGB matches HIF1A: hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	44	2.798525e-2	1.000000e+0	3.911575e-1	3.573310e+1	2.798525e-2	1	2.798525e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	5.820754e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$AP2_Q6	Motif MKCCCSCNGGCG matches GTF3A: general transcription factor IIIA	45	2.806717e-2	1.000000e+0	3.835847e-1	3.562881e+1	2.806717e-2	1	2.806717e-2	1.000000e+0	49	2.730472e-2	1.000000e+0	3.427021e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$SRY_01	Motif AAACWAM matches SRY: sex determining region Y	46	2.819188e-2	1.000000e+0	3.769132e-1	3.547121e+1	2.819188e-2	1	2.819188e-2	1.000000e+0	14	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$PAX4_01	Motif NGNVGTCANGCGTGNNSNNYN matches PAX4: paired box gene 4	47	2.866208e-2	1.000000e+0	3.750464e-1	3.488931e+1	2.866208e-2	1	2.866208e-2	1.000000e+0	54	2.752338e-2	1.000000e+0	3.134607e-1	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$NGFIC_01	Motif WTGCGTGGGYGG matches EGR4: early growth response 4	48	2.881666e-2	1.000000e+0	3.692135e-1	3.470215e+1	2.881666e-2	1	2.881666e-2	1.000000e+0	46	2.697668e-2	1.000000e+0	3.606665e-1	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$EGR1_01	Motif WTGCGTGGGCGK matches EGR1: early growth response 1	49	2.888416e-2	1.000000e+0	3.625257e-1	3.462106e+1	2.888416e-2	1	2.888416e-2	1.000000e+0	63	2.817922e-2	1.000000e+0	2.750829e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MSX1_01	Motif CNGTAWNTG matches MSX1: msh homeobox homolog 1 (Drosophila)	50	2.896594e-2	1.000000e+0	3.562811e-1	3.452330e+1	2.896594e-2	1	2.896594e-2	1.000000e+0	10	1.919691e-2	1.000000e+0	1.000000e+0	5.184195e+1	1.928940e-2	1	174	5.000000e-1	5.747126e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MYOD_01	Motif SRACAGGTGKYG matches MYOD1: myogenic differentiation 1	51	2.903710e-2	1.000000e+0	3.501533e-1	3.443870e+1	2.903710e-2	1	2.903710e-2	1.000000e+0	49	2.730472e-2	1.000000e+0	3.427021e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$AP4_Q6_01	Motif RNCAGCTGC matches TFAP4: transcription factor AP-4 (activating enhancer binding protein 4)	52	2.995730e-2	1.000000e+0	3.543027e-1	3.338085e+1	2.995730e-2	1	2.995730e-2	1.000000e+0	57	2.763270e-2	1.000000e+0	2.981423e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E12_Q6	Motif RRCAGGTGNCV matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	53	3.028492e-2	1.000000e+0	3.514194e-1	3.301973e+1	3.028492e-2	1	3.028492e-2	1.000000e+0	54	2.752338e-2	1.000000e+0	3.134607e-1	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E2F1_Q3_01	Motif TTGGCGCGRAANNGNM matches E2F1: E2F transcription factor 1	54	3.075994e-2	1.000000e+0	3.503215e-1	3.250982e+1	3.075994e-2	1	3.075994e-2	1.000000e+0	40	2.664858e-2	1.000000e+0	4.097219e-1	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TGANNYRGCA_V$TCF11MAFG_01	Motif TGANNYRGCA matches NFE2L1: nuclear factor (erythroid-derived 2)-like 1&lt;br&gt; MAFG: v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)	55	3.091129e-2	1.000000e+0	3.456444e-1	3.235064e+1	3.091129e-2	1	3.091129e-2	1.000000e+0	74	3.156421e-2	1.000000e+0	2.623242e-1	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	DHDDS
MSigDB Predicted Promoter Motifs	V$NF1_Q6	Motif NNTTGGCNNNNNNCCNNN matches NF1: neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	56	3.110640e-2	1.000000e+0	3.416149e-1	3.214773e+1	3.110640e-2	1	3.110640e-2	1.000000e+0	49	2.730472e-2	1.000000e+0	3.427021e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$LMO2COM_01	Motif CNNCAGGTGBNN matches LMO2: LIM domain only 2 (rhombotin-like 1)	57	3.112386e-2	1.000000e+0	3.358101e-1	3.212969e+1	3.112386e-2	1	3.112386e-2	1.000000e+0	60	2.774202e-2	1.000000e+0	2.843557e-1	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$CACCCBINDINGFACTOR_Q6	Motif CANCCNNWGGGTGDGG (no known TF)	58	3.138226e-2	1.000000e+0	3.327602e-1	3.186514e+1	3.138226e-2	1	3.138226e-2	1.000000e+0	68	2.850706e-2	1.000000e+0	2.578212e-1	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$AP4_01	Motif WGARYCAGCTGYGGNCNK matches TFAP4: transcription factor AP-4 (activating enhancer binding protein 4)	59	3.231890e-2	1.000000e+0	3.368834e-1	3.094165e+1	3.231890e-2	1	3.231890e-2	1.000000e+0	57	2.763270e-2	1.000000e+0	2.981423e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$NF1_Q6_01	Motif NTGGNNNNNNGCCAANN matches NF1: neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	60	3.264873e-2	1.000000e+0	3.346495e-1	3.062906e+1	3.264873e-2	1	3.264873e-2	1.000000e+0	63	2.817922e-2	1.000000e+0	2.750829e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$AP4_Q5	Motif VDCAGCTGNN matches TFAP4: transcription factor AP-4 (activating enhancer binding protein 4)	61	3.376240e-2	1.000000e+0	3.403914e-1	2.961875e+1	3.376240e-2	1	3.376240e-2	1.000000e+0	62	2.806993e-2	1.000000e+0	2.784356e-1	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$CEBP_Q2	Motif NNATTGCNNAANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	62	3.529750e-2	1.000000e+0	3.501284e-1	2.833062e+1	3.529750e-2	1	3.529750e-2	1.000000e+0	18	2.424086e-2	1.000000e+0	8.282294e-1	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MAF_Q6	Motif TRGRRGGAAGTKKSST matches MAF: v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)	63	3.604380e-2	1.000000e+0	3.518561e-1	2.774403e+1	3.604380e-2	1	3.604380e-2	1.000000e+0	57	2.763270e-2	1.000000e+0	2.981423e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$PR_Q2	Motif NWNAGRACAN matches NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	64	3.657682e-2	1.000000e+0	3.514804e-1	2.733972e+1	3.657682e-2	1	3.657682e-2	1.000000e+0	54	2.752338e-2	1.000000e+0	3.134607e-1	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$E47_02	Motif NNNMRCAGGTGTTMNN matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	65	3.750828e-2	1.000000e+0	3.548860e-1	2.666078e+1	3.750828e-2	1	3.750828e-2	1.000000e+0	35	2.642982e-2	1.000000e+0	4.644097e-1	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$CHOP_01	Motif NNRTGCAATMCCC matches DDIT3: DNA-damage-inducible transcript 3&lt;br&gt; CEBPA DIFF GENES	66	3.858504e-2	1.000000e+0	3.595424e-1	2.591678e+1	3.858504e-2	1	3.858504e-2	1.000000e+0	24	2.522619e-2	1.000000e+0	6.464211e-1	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$AMEF2_Q6	Motif CKGDYTAAAAATAACYMM (no known TF)	67	4.025690e-2	1.000000e+0	3.695223e-1	2.484046e+1	4.025690e-2	1	4.025690e-2	1.000000e+0	44	2.686732e-2	1.000000e+0	3.755319e-1	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$CEBP_Q3	Motif NNNTKNNGNAAN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	68	4.116827e-2	1.000000e+0	3.723307e-1	2.429055e+1	4.116827e-2	1	4.116827e-2	1.000000e+0	49	2.730472e-2	1.000000e+0	3.427021e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$TATA_C	Motif NCTATAAAAR matches TAF&lt;br&gt; TATA	69	4.326028e-2	1.000000e+0	3.855808e-1	2.311589e+1	4.326028e-2	1	4.326028e-2	1.000000e+0	71	3.036376e-2	1.000000e+0	2.630100e-1	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$CRX_Q4	Motif YNNNTAATCYCMN matches CRX: cone-rod homeobox	70	4.403554e-2	1.000000e+0	3.868837e-1	2.270893e+1	4.403554e-2	1	4.403554e-2	1.000000e+0	72	3.047293e-2	1.000000e+0	2.602896e-1	3.256498e+1	3.070783e-2	1	277	5.000000e-1	3.610108e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$MMEF2_Q6	Motif CKSNYTAAAAAWRMCY (no known TF)	71	4.418899e-2	1.000000e+0	3.827638e-1	2.263007e+1	4.418899e-2	1	4.418899e-2	1.000000e+0	65	2.828851e-2	1.000000e+0	2.676528e-1	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$POU6F1_01	Motif GCATAAWTTAT matches POU6F1: POU domain, class 6, transcription factor 1	72	4.492839e-2	1.000000e+0	3.837633e-1	2.225764e+1	4.492839e-2	1	4.492839e-2	1.000000e+0	27	2.555453e-2	1.000000e+0	5.820754e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	V$NKX25_02	Motif CWTAATTG matches NKX2-5: NK2 transcription factor related, locus 5 (Drosophila)	73	4.557185e-2	1.000000e+0	3.839272e-1	2.194337e+1	4.557185e-2	1	4.557185e-2	1.000000e+0	53	2.741405e-2	1.000000e+0	3.181064e-1	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	AAAYWAACM_V$HFH4_01	Motif AAAYWAACM matches FOXJ1: forkhead box J1	74	4.760964e-2	1.000000e+0	3.956747e-1	2.100415e+1	4.760964e-2	1	4.760964e-2	1.000000e+0	47	2.719538e-2	1.000000e+0	3.558544e-1	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	YATTNATC_UNKNOWN	Motif YATTNATC (no known TF)	75	6.241625e-2	1.000000e+0	5.118132e-1	1.602147e+1	6.241625e-2	1	6.241625e-2	1.000000e+0	75	3.907735e-2	1.000000e+0	3.204343e-1	2.533848e+1	3.946566e-2	1	356	5.000000e-1	2.808989e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	RNGTGGGC_UNKNOWN	Motif RNGTGGGC (no known TF)	76	8.493341e-2	1.000000e+0	6.872901e-1	1.177393e+1	8.493341e-2	1	8.493341e-2	1.000000e+0	80	8.109914e-2	1.000000e+0	6.234496e-1	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	YCATTAA_UNKNOWN	Motif YCATTAA (no known TF)	77	8.885768e-2	1.000000e+0	7.097074e-1	1.125395e+1	8.885768e-2	1	8.885768e-2	1.000000e+0	76	5.875424e-2	1.000000e+0	4.754455e-1	1.676673e+1	5.964193e-2	1	538	5.000000e-1	1.858736e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	CACGTG_V$MYC_Q2	Motif CACGTG matches MYC: v-myc myelocytomatosis viral oncogene homolog (avian)	78	9.316007e-2	1.000000e+0	7.345313e-1	1.073421e+1	9.316007e-2	1	9.316007e-2	1.000000e+0	86	1.063225e-1	1.000000e+0	7.603295e-1	9.148580e+0	1.093066e-1	1	986	5.000000e-1	1.014199e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TGCCAAR_V$NF1_Q6	Motif TGCCAAR matches NF1: neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	79	9.403888e-2	1.000000e+0	7.320748e-1	1.063390e+1	9.403888e-2	1	9.403888e-2	1.000000e+0	77	7.417853e-2	1.000000e+0	5.924649e-1	1.322654e+1	7.560557e-2	1	682	5.000000e-1	1.466276e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	CAGGTA_V$AREB6_01	Motif CAGGTA matches TCF8: transcription factor 8 (represses interleukin 2 expression)	80	1.038344e-1	1.000000e+0	7.982269e-1	9.630718e+0	1.038344e-1	1	1.038344e-1	1.000000e+0	82	8.205534e-2	1.000000e+0	6.154150e-1	1.193188e+1	8.380910e-2	1	756	5.000000e-1	1.322751e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TGTTTGY_V$HNF3_Q6	Motif TGTTTGY matches FOXA1: forkhead box A1	81	1.063406e-1	1.000000e+0	8.074009e-1	9.403749e+0	1.063406e-1	1	1.063406e-1	1.000000e+0	78	7.716290e-2	1.000000e+0	6.083998e-1	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	CTGCAGY_UNKNOWN	Motif CTGCAGY (no known TF)	82	1.078530e-1	1.000000e+0	8.088975e-1	9.271883e+0	1.078530e-1	1	1.078530e-1	1.000000e+0	79	7.886609e-2	1.000000e+0	6.139575e-1	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	GATTGGY_V$NFY_Q6_01	Motif GATTGGY (no known TF)	83	1.117321e-1	1.000000e+0	8.278945e-1	8.949976e+0	1.117321e-1	1	1.117321e-1	1.000000e+0	87	1.216620e-1	1.000000e+0	8.600245e-1	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TGACAGNY_V$MEIS1_01	Motif TGACAGNY matches MEIS1: Meis1, myeloid ecotropic viral integration site 1 homolog (mouse)	84	1.133519e-1	1.000000e+0	8.298978e-1	8.822084e+0	1.133519e-1	1	1.133519e-1	1.000000e+0	83	8.566313e-2	1.000000e+0	6.347328e-1	1.141835e+1	8.757829e-2	1	790	5.000000e-1	1.265823e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	GCANCTGNY_V$MYOD_Q6	Motif GCANCTGNY matches MYOD1: myogenic differentiation 1	85	1.148568e-1	1.000000e+0	8.310227e-1	8.706491e+0	1.148568e-1	1	1.148568e-1	1.000000e+0	84	9.560063e-2	1.000000e+0	6.999332e-1	1.020419e+1	9.799900e-2	1	884	5.000000e-1	1.131222e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TAATTA_V$CHX10_01	Motif TAATTA matches VSX1: visual system homeobox 1 homolog, CHX10-like (zebrafish)	86	1.272565e-1	1.000000e+0	9.100319e-1	7.858145e+0	1.272565e-1	1	1.272565e-1	1.000000e+0	81	8.194912e-2	1.000000e+0	6.222063e-1	1.194768e+1	8.369824e-2	1	755	5.000000e-1	1.324503e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TTANTCA_UNKNOWN	Motif TTANTCA (no known TF)	87	1.354023e-1	1.000000e+0	9.571542e-1	7.385397e+0	1.354023e-1	1	1.354023e-1	1.000000e+0	85	9.802388e-2	1.000000e+0	7.092316e-1	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TATAAA_V$TATA_01	Motif TATAAA matches TAF&lt;br&gt; TATA	88	1.585244e-1	1.000000e+0	1.000000e+0	6.308178e+0	1.585244e-1	1	1.585244e-1	1.000000e+0	88	1.364568e-1	1.000000e+0	9.536470e-1	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	CAGCTG_V$AP4_Q5	Motif CAGCTG matches REPIN1: replication initiator 1	89	1.626399e-1	1.000000e+0	1.000000e+0	6.148551e+0	1.626399e-1	1	1.626399e-1	1.000000e+0	89	1.532695e-1	1.000000e+0	1.000000e+0	6.264236e+0	1.596364e-1	1	1440	5.000000e-1	6.944444e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	GGGAGGRR_V$MAZ_Q6	Motif GGGAGGRR matches MAZ: MYC-associated zinc finger protein (purine-binding transcription factor)	90	2.285624e-1	1.000000e+0	1.000000e+0	4.375173e+0	2.285624e-1	1	2.285624e-1	1.000000e+0	92	2.271738e-1	1.000000e+0	1.000000e+0	4.135947e+0	2.417826e-1	1	2181	5.000000e-1	4.585053e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	GGGCGGR_V$SP1_Q6	Motif GGGCGGR matches SP1: Sp1 transcription factor	91	2.425080e-1	1.000000e+0	1.000000e+0	4.123575e+0	2.425080e-1	1	2.425080e-1	1.000000e+0	94	2.900650e-1	1.000000e+0	1.000000e+0	3.176232e+0	3.148384e-1	1	2840	5.000000e-1	3.521127e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	CAGGTG_V$E12_Q6	Motif CAGGTG matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	92	2.657598e-1	1.000000e+0	1.000000e+0	3.762796e+0	2.657598e-1	1	2.657598e-1	1.000000e+0	93	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	TTGTTT_V$FOXO4_01	Motif TTGTTT matches MLLT7: myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7	93	2.767434e-1	1.000000e+0	1.000000e+0	3.613455e+0	2.767434e-1	1	2.767434e-1	1.000000e+0	91	2.050899e-1	1.000000e+0	1.000000e+0	4.611708e+0	2.168394e-1	1	1956	5.000000e-1	5.112474e-4	unnamed	HMGN2
MSigDB Predicted Promoter Motifs	AACTTT_UNKNOWN	Motif AACTTT (no known TF)	94	2.964325e-1	1.000000e+0	1.000000e+0	3.373449e+0	2.964325e-1	1	2.964325e-1	1.000000e+0	90	1.917900e-1	1.000000e+0	1.000000e+0	4.950878e+0	2.019844e-1	1	1822	5.000000e-1	5.488474e-4	unnamed	HMGN2
MSigDB miRNA Motifs	GTCAACC,MIR-380-5P	Targets of MicroRNA GTCAACC,MIR-380-5P	1	4.335621e-3	9.581722e-1	9.581722e-1	2.306475e+2	4.335621e-3	1	4.335621e-3	1.000000e+0	1	2.326740e-3	5.142095e-1	5.142095e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	HMGN2
MSigDB miRNA Motifs	CCACACA,MIR-147	Targets of MicroRNA CCACACA,MIR-147	2	8.128582e-3	1.000000e+0	8.982083e-1	1.230227e+2	8.128582e-3	1	8.128582e-3	1.000000e+0	2	6.530143e-3	1.000000e+0	7.215808e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	DHDDS
MSigDB miRNA Motifs	TACAATC,MIR-508	Targets of MicroRNA TACAATC,MIR-508	3	1.060540e-2	1.000000e+0	7.812645e-1	9.429160e+1	1.060540e-2	1	1.060540e-2	1.000000e+0	3	6.861613e-3	1.000000e+0	5.054722e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	DHDDS
MSigDB miRNA Motifs	CAGGGTC,MIR-504	Targets of MicroRNA CAGGGTC,MIR-504	4	1.223315e-2	1.000000e+0	6.758815e-1	8.174511e+1	1.223315e-2	1	1.223315e-2	1.000000e+0	4	9.069997e-3	1.000000e+0	5.011173e-1	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	HMGN2
MSigDB miRNA Motifs	ACTGAAA,MIR-30A-3P,MIR-30E-3P	Targets of MicroRNA ACTGAAA,MIR-30A-3P,MIR-30E-3P	5	3.138030e-2	1.000000e+0	1.000000e+0	3.186713e+1	3.138030e-2	1	3.138030e-2	1.000000e+0	5	2.128185e-2	1.000000e+0	9.406578e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	DHDDS
MSigDB miRNA Motifs	CACCAGC,MIR-138	Targets of MicroRNA CACCAGC,MIR-138	6	3.203648e-2	1.000000e+0	1.000000e+0	3.121441e+1	3.203648e-2	1	3.203648e-2	1.000000e+0	6	2.391230e-2	1.000000e+0	8.807697e-1	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	DHDDS
MSigDB miRNA Motifs	CACTTTG,MIR-520G,MIR-520H	Targets of MicroRNA CACTTTG,MIR-520G,MIR-520H	7	3.529122e-2	1.000000e+0	1.000000e+0	2.833566e+1	3.529122e-2	1	3.529122e-2	1.000000e+0	7	2.577339e-2	1.000000e+0	8.137027e-1	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	DHDDS
MSigDB miRNA Motifs	CAGCTTT,MIR-320	Targets of MicroRNA CAGCTTT,MIR-320	8	3.834921e-2	1.000000e+0	1.000000e+0	2.607616e+1	3.834921e-2	1	3.834921e-2	1.000000e+0	8	2.763270e-2	1.000000e+0	7.633533e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	DHDDS
MSigDB miRNA Motifs	AATGTGA,MIR-23A,MIR-23B	Targets of MicroRNA AATGTGA,MIR-23A,MIR-23B	9	6.786184e-2	1.000000e+0	1.000000e+0	1.473582e+1	6.786184e-2	1	6.786184e-2	1.000000e+0	9	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	HMGN2
MSigDB miRNA Motifs	TGCTGCT,MIR-15A,MIR-16,MIR-15B,MIR-195,MIR-424,MIR-497	Targets of MicroRNA TGCTGCT,MIR-15A,MIR-16,MIR-15B,MIR-195,MIR-424,MIR-497	10	7.670739e-2	1.000000e+0	1.000000e+0	1.303655e+1	7.670739e-2	1	7.670739e-2	1.000000e+0	10	6.369530e-2	1.000000e+0	1.000000e+0	1.544606e+1	6.474142e-2	1	584	5.000000e-1	1.712329e-3	unnamed	DHDDS
InterPro	IPR018520	Di-trans-poly-cis-decaprenylcistransferase-like, conserved site	1	1.948067e-5	1.835469e-1	1.835469e-1	5.133294e+4	1.948067e-5	1	1.948067e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	DHDDS
InterPro	IPR001441	Decaprenyl diphosphate synthase-like	2	1.226352e-4	1.000000e+0	5.777344e-1	8.154269e+3	1.226352e-4	1	1.226352e-4	1.000000e+0	2	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	DHDDS
InterPro	IPR000079	High mobility group nucleosome-binding domain-containing family	3	5.968674e-4	1.000000e+0	1.000000e+0	1.675414e+3	5.968674e-4	1	5.968674e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	HMGN2
TreeFam	TF323753	DHDDS	1	1.948067e-5	1.582999e-1	1.582999e-1	5.133294e+4	1.948067e-5	1	1.948067e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	DHDDS
HGNC Gene Families	HMG	HMG	1	1.458207e-3	6.970229e-1	6.970229e-1	6.857738e+2	1.458207e-3	1	1.458207e-3	1.000000e+0	1	1.219107e-3	5.827331e-1	5.827331e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	HMGN2
Ensembl Genes	372	DHDDS	1	1.948067e-5	3.514508e-1	3.514508e-1	5.133294e+4	1.948067e-5	1	1.948067e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	DHDDS
Ensembl Genes	373	HMGN2	2	3.756864e-5	6.777758e-1	3.388879e-1	2.661794e+4	3.756864e-5	1	3.756864e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	HMGN2
MSigDB Oncogenic Signatures	RB_P107_DN.V1_UP	Genes up-regulated in primary keratinocytes from RB1 and RBL1 [Gene ID=5925, 5933] skin specific knockout mice.	1	1.211958e-2	1.000000e+0	1.000000e+0	8.251110e+1	1.211958e-2	1	1.211958e-2	1.000000e+0	1	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE17721_12H_VS_24H_LPS_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus those stimulated at 24 h.	1	1.107715e-2	1.000000e+0	1.000000e+0	9.027589e+1	1.107715e-2	1	1.107715e-2	1.000000e+0	6	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN	Genes down-regulated in comparison of polysome bound (translated) mRNA versus total mRNA 4 h after LPS (TLR4 agonist) stimulation.	2	1.185740e-2	1.000000e+0	1.000000e+0	8.433553e+1	1.185740e-2	1	1.185740e-2	1.000000e+0	1	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.	3	1.280192e-2	1.000000e+0	1.000000e+0	7.811330e+1	1.280192e-2	1	1.280192e-2	1.000000e+0	20	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.	4	1.311139e-2	1.000000e+0	1.000000e+0	7.626956e+1	1.311139e-2	1	1.311139e-2	1.000000e+0	9	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 72 h.	5	1.402503e-2	1.000000e+0	1.000000e+0	7.130110e+1	1.402503e-2	1	1.402503e-2	1.000000e+0	18	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 12 h.	6	1.464114e-2	1.000000e+0	1.000000e+0	6.830071e+1	1.464114e-2	1	1.464114e-2	1.000000e+0	15	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN	Genes down-regulated in comparison of naive B cells versus plasma cells.	7	1.485062e-2	1.000000e+0	1.000000e+0	6.733726e+1	1.485062e-2	1	1.485062e-2	1.000000e+0	21	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_NEUTROPHIL_UP	Genes up-regulated in comparison of mast cells versus neutrophils.	8	1.507882e-2	1.000000e+0	1.000000e+0	6.631818e+1	1.507882e-2	1	1.507882e-2	1.000000e+0	11	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute RSV infection.	9	1.515483e-2	1.000000e+0	1.000000e+0	6.598556e+1	1.515483e-2	1	1.515483e-2	1.000000e+0	9	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.	10	1.543044e-2	1.000000e+0	1.000000e+0	6.480697e+1	1.543044e-2	1	1.543044e-2	1.000000e+0	13	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP	Genes up-regulated in comparison of CD4- [GeneID=920] CD8- thymocytes versus CD4+ [GeneID=920] CD8- thymocytes.	11	1.570511e-2	1.000000e+0	1.000000e+0	6.367354e+1	1.570511e-2	1	1.570511e-2	1.000000e+0	7	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to 5 worm/well B. malayi.	12	1.581932e-2	1.000000e+0	1.000000e+0	6.321385e+1	1.581932e-2	1	1.581932e-2	1.000000e+0	17	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP	Genes up-regulated in comparison of CD4- [GeneID=920] CD8- thymocytes versus CD4- [GeneID=920] CD8+ thymocytes.	13	1.635340e-2	1.000000e+0	1.000000e+0	6.114936e+1	1.635340e-2	1	1.635340e-2	1.000000e+0	8	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN	Genes down-regulated in comparison of IgM-memory B cells versus plasma cells.	14	1.662974e-2	1.000000e+0	1.000000e+0	6.013323e+1	1.662974e-2	1	1.662974e-2	1.000000e+0	22	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_0.5H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	15	1.713390e-2	1.000000e+0	1.000000e+0	5.836384e+1	1.713390e-2	1	1.713390e-2	1.000000e+0	3	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	Genes down-regulated in comparison of IgD- peripheral blood B cells versus pre-germinal center B cells.	16	1.727434e-2	1.000000e+0	1.000000e+0	5.788933e+1	1.727434e-2	1	1.727434e-2	1.000000e+0	3	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN	Genes down-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	17	1.752043e-2	1.000000e+0	1.000000e+0	5.707622e+1	1.752043e-2	1	1.752043e-2	1.000000e+0	16	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).	18	1.761152e-2	1.000000e+0	1.000000e+0	5.678101e+1	1.761152e-2	1	1.761152e-2	1.000000e+0	11	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	Genes down-regulated in comparison of IgD+ B cells from peripheral blood versus CD19 pre-germinal center tonsil B cell	19	1.821527e-2	1.000000e+0	1.000000e+0	5.489899e+1	1.821527e-2	1	1.821527e-2	1.000000e+0	19	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated memory CD4 [GeneID=920] CD8 T cells.	20	1.858279e-2	1.000000e+0	1.000000e+0	5.381322e+1	1.858279e-2	1	1.858279e-2	1.000000e+0	13	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	DHDDS
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP	Genes up-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	21	1.872221e-2	1.000000e+0	1.000000e+0	5.341248e+1	1.872221e-2	1	1.872221e-2	1.000000e+0	2	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	Genes down-regulated in plasma cells versus memory B cells.	22	1.912160e-2	1.000000e+0	1.000000e+0	5.229687e+1	1.912160e-2	1	1.912160e-2	1.000000e+0	3	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	HMGN2
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of B cells versus effector memory CD4 [GeneID=920] T cells.	23	2.279849e-2	1.000000e+0	1.000000e+0	4.386255e+1	2.279849e-2	1	2.279849e-2	1.000000e+0	22	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	DHDDS
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
